Skip to main content
SpringerLink
Log in

Immunotherapy in Rasmussen’s encephalitis: when should it be taken into account?

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Vezzani A, Friedman A, Dingledine RJ (2012) The role of inflammation in epileptogenesis. Neuropharmacology. doi:10.1016/j.neuropharm.2012.04.004

    PubMed  Google Scholar 

  2. Specchio N, Fusco L, Claps D, Vigevano F (2010) Epileptic encephalopathy in children possibly related to immune-mediated pathogenesis. Brain Dev 32(1):51–56

    Article  PubMed  Google Scholar 

  3. Granata T, Cross H, Theodore W, Avanzini G (2011) Immune-mediated epilepsies. Epilepsia 52(Suppl 3):5–11. doi:10.1111/j.1528-1167.2011.03029.x

    Article  PubMed  Google Scholar 

  4. Bien CG, Schramm J (2009) Treatment of Rasmussen encephalitis half a century after its initial description: promising prospects and a dilemma. Epilepsy Res 86(2–3):101–112

    Article  PubMed  Google Scholar 

  5. Granata T, Fusco L, Gobbi G, Freri E, Ragona F, Broggi G, Mantegazza R, Giordano L, Villani F, Capovilla G, Vigevano F, Bernardina BD, Spreafico R, Antozzi C (2003) Experience with immunomodulatory treatments in Rasmussen’s encephalitis. Neurology 61(12):1807–1810

    Article  PubMed  CAS  Google Scholar 

  6. Papetti L, Nicita F, Granata T, Guerrini R, Ursitti F, Properzi E, Iannetti P, Spalice A (2011) Early add-on immunoglobulin administration in Rasmussen encephalitis: the hypothesis of neuroimmunomodulation. Med Hypotheses 77(5):917–920

    Article  PubMed  CAS  Google Scholar 

  7. Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, Lassmann H, Mantegazza R, Villemure JG, Spreafico R, Elger CE (2005) Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 128(Pt 3):454–471

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors report no conflict of interest.

Author information

Authors and Affiliations

  1. Child Neurology Division, Department of Pediatrics, “Sapienza” University of Rome, Viale Regina Elena 324, 00161, Rome, Italy

    L. Papetti, A. Spalice, F. Nicita, F. Ursitti & P. Iannetti

Authors
  1. L. Papetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Spalice
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Nicita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Ursitti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Iannetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Spalice.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papetti, L., Spalice, A., Nicita, F. et al. Immunotherapy in Rasmussen’s encephalitis: when should it be taken into account?. Neurol Sci 34, 1247–1248 (2013). https://doi.org/10.1007/s10072-012-1196-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-012-1196-5

Keywords

Search

Navigation